Evidence map›Paper›PMID 36102052›Full record

ArticleAfrican journal of AIDS research : AJAR2022

"

Kawango Agot, Miriam Hartmann, Sophie Otticha, Alexandra Minnis, Jacob Onyango, Marylyn Ochillo, Sarah T Roberts

Abstract read
In one paragraph

Article in African journal of AIDS research : AJAR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. medRxiv : the preprint server for health sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kawango AgotImpact Research and Development Organisation, Kisumu, Kenya.ORCID 0000-0002-6153-8950
Miriam HartmannWomen's Global Health Imperative, RTI International, Berkeley, CA, USA.ORCID 0000-0001-8109-9679
Sophie OttichaImpact Research and Development Organisation, Kisumu, Kenya.ORCID 0000-0002-1398-2379
Alexandra MinnisWomen's Global Health Imperative, RTI International, Berkeley, CA, USA.ORCID 0000-0002-2943-2005
Jacob OnyangoImpact Research and Development Organisation, Kisumu, Kenya.ORCID 0000-0003-4828-9328
Marylyn OchilloImpact Research and Development Organisation, Kisumu, Kenya.ORCID 0000-0002-6670-3580
Sarah T RobertsWomen's Global Health Imperative, RTI International, Berkeley, CA, USA.ORCID 0000-0002-3318-9781

Funding

Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in KenyaR34MH114519 · NIMH · RESEARCH TRIANGLE INSTITUTE · PI ROBERTS, SARAH TYLER · 2017 to 2019
$644k
NIMH NIH HHS R34 MH114519
6 · The paper itself

Abstract

The HIV infection rate is higher among adolescent girls and young women (AGYW) in Africa than men in the same age range. Pre-exposure prophylaxis (PrEP) can be used by women discreetly; however, for most AGYW, male partner approval is desired. We explored PrEP use in the context of relationship violence and power dynamics through focus group discussions and support club sessions with AGYW, in-depth interviews and male sensitisation sessions with male partners of AGYW, and joint sessions with AGYW and their male partners. Many male partners reported hesitancy in supporting partner's PrEP use without sufficient information; most of these became supportive following their engagement in study activities; and most preferred participation in decisions around PrEP use. For AGYW, male involvement minimised partner violence around their PrEP use. The findings support the need for correct PrEP information to be provided to male partners of AGYW and to involve them early on, in decision-making about PrEP use. This is likely to improve uptake of and adherence to PrEP.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentFemaleHumansKenyaMaleSocial SupportAnti-HIV Agentsadolescent girls and young womenintimate partner violencemale partnerspre-exposure prophylaxis

Identifiers

PMID36102052
PMCPMC10102710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.